388 related articles for article (PubMed ID: 3989296)
1. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
[TBL] [Abstract][Full Text] [Related]
2. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells in the thymus. Studies in mice with severe combined immune deficiency.
Garni-Wagner BA; Witte PL; Tutt MM; Kuziel WA; Tucker PW; Bennett M; Kumar V
J Immunol; 1990 Feb; 144(3):796-803. PubMed ID: 2136898
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
5. Generation of natural killer cell lines from murine long-term bone marrow cultures.
Yung YP; Okumura K; Moore MA
J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
7. Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity.
Chang HL; Zaroukian MH; Morrison MH; Esselman WJ
Nat Immun Cell Growth Regul; 1989; 8(2):89-99. PubMed ID: 2788243
[TBL] [Abstract][Full Text] [Related]
8. Suppression of B-cell differentiation by natural killer (asialo GM1+) cells in mice.
Suzuki S; Suzuki R; Onta T; Kumagai K
Nat Immun Cell Growth Regul; 1986; 5(2):75-89. PubMed ID: 3487716
[TBL] [Abstract][Full Text] [Related]
9. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice.
Hasui M; Saikawa Y; Miura M; Takano N; Ueno Y; Yachie A; Miyawaki T; Taniguchi N
Cell Immunol; 1989 Apr; 120(1):230-9. PubMed ID: 2784720
[TBL] [Abstract][Full Text] [Related]
10. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes.
Itoh H; Abo T; Sugawara S; Kanno A; Kumagai K
J Immunol; 1988 Jul; 141(1):315-23. PubMed ID: 3379309
[TBL] [Abstract][Full Text] [Related]
11. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.
Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J
Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer activity in sponge matrix allografts.
Hoffman RA; Ascher NL; Jordan ML; Migliori RJ; Simmons RL
J Immunol; 1988 Mar; 140(5):1702-10. PubMed ID: 3257981
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of natural killer activity by calcitonin gene-related peptide.
Umeda Y; Arisawa M
Immunopharmacol Immunotoxicol; 1989; 11(2-3):309-20. PubMed ID: 2559931
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
16. Natural killer (NK) cells and graft-versus-host disease (GVHD): no correlation between the NK cell levels and GVHD in the murine P----F1 model.
Varkila K; Hurme M
Immunology; 1985 Jan; 54(1):121-6. PubMed ID: 3972429
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of scid mice.
Tutt MM; Schuler W; Kuziel WA; Tucker PW; Bennett M; Bosma MJ; Kumar V
J Immunol; 1987 Apr; 138(7):2338-44. PubMed ID: 3559207
[TBL] [Abstract][Full Text] [Related]
18. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
19. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity of gut mucosal lymphoid cells in mice.
Tagliabue A; Luini W; Soldateschi D; Boraschi D
Eur J Immunol; 1981 Nov; 11(11):919-22. PubMed ID: 7327195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]